JPM: Biogen bullish on Alzheimer's drug approval, sees Lilly da...

01/11/21

JPM: Biogen bullish on Alzheimer's drug approval, sees Lilly data as positive despite AdComm rejection FierceBiotech

[more]

Feeds Categories:
- Liquidation,
- News